Solvonis Therapeutics to acquire Awakn Life Sciences
LONDON: Solvonis Therapeutics plc announced Monday it has entered into an arrangement agreement to acquire Awakn Life Sciences Corp. The acquisition involves all issued and outstanding common shares, restricted share units, and deferred share units of Awakn. Solvonis will issue…